Gadolinium DTPA

• 

  Subject Areas on Research

  • "Keyhole" method for accelerating imaging of contrast agent uptake. 
  • 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging. 
  • A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging. 
  • A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial. 
  • Abbreviated screening protocol for breast MRI: a feasibility study. 
  • Accuracy of contrast-enhanced magnetic resonance angiography in chronic thromboembolic disease. 
  • Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRI. 
  • An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. 
  • Assessment of whole-brain vasodilatory capacity with acetazolamide challenge at 1.5 T using dynamic contrast imaging with frequency-shifted burst. 
  • Automatic motion correction for breast MR imaging. 
  • Bathing the brain. 
  • Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and Definity in Mice. 
  • Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings? 
  • Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer? 
  • Can combining triple-arterial phase acquisition with fluoroscopic triggering provide both optimal early and late hepatic arterial phase images during gadoxetic acid-enhanced MRI? 
  • Cardiovascular phenotyping of the mouse heart using a 4D radial acquisition and liposomal Gd-DTPA-BMA. 
  • Castleman disease of the adrenal gland: MR imaging features. 
  • Central veins of the chest: evaluation with time-resolved MR angiography. 
  • Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. 
  • Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. 
  • Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. 
  • Comparison of T1ρ, dGEMRIC, and quantitative T2 MRI in preoperative ACL rupture patients. 
  • Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. 
  • Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. 
  • Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI. 
  • Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. 
  • Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. 
  • Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. 
  • Contrast-enhanced MR imaging of neurocutaneous melanosis. 
  • Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. 
  • Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound. 
  • Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. 
  • Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms. 
  • DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study. 
  • Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity. 
  • Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI. 
  • Delayed magnetic resonance hepatic imaging with gadolinium-DTPA. 
  • Demonstration of dural sinus occlusion by the use of MR angiography. 
  • Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. 
  • Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity. 
  • Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features. 
  • Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. 
  • Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. 
  • Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. 
  • Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. 
  • Dynamic contrast enhanced-MRI in head and neck cancer patients: Variability of the precontrast longitudinal relaxation time (T10). 
  • Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters. 
  • Dynamic contrast-enhanced MRI promotes early detection of toxin-induced acute kidney injury. 
  • Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI. 
  • Dynamic susceptibility contrast MRI with localized arterial input functions. 
  • Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. 
  • Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. 
  • Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. 
  • Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. 
  • Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. 
  • Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. 
  • Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. 
  • Evaluation of acute renal failure with magnetic resonance imaging using gradient-echo and Gd-DTPA. 
  • Evaluation of intracranial cysts by intraoperative MR. 
  • Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. 
  • Evaluation of the biliary tree and gallbladder with hepatocellular MR contrast agents. 
  • Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. 
  • False positive images in the follow-up of patients with brain tumors. 
  • False-positive MRI detection of recurrent or metastatic pediatric infratentorial tumors. 
  • Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media. 
  • Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis? 
  • Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. 
  • Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis. 
  • Gadolinium-enhanced CT angiography of endovascular stent-grafts. 
  • Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? 
  • Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination. 
  • Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. 
  • Gadoxetate disodium-enhanced magnetic resonance cholangiography for the noninvasive detection of an active bile duct leak after laparoscopic cholecystectomy. 
  • Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. 
  • Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. 
  • Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. 
  • Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary intracranial CNS tumor in children. 
  • Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? 
  • Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. 
  • Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. 
  • Hepatobiliary phase MRI: impact on planning image-guided liver tumor ablations. 
  • Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression. 
  • Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? 
  • Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. 
  • Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? 
  • How we perform delayed enhancement imaging. 
  • Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. 
  • In situ analysis of protein chromatography and column efficiency using magnetic resonance imaging. 
  • Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. 
  • Intraoperative dynamic MRI: localization of sites of brain tumor recurrence after high-dose radiotherapy. 
  • Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. 
  • Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. 
  • LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement. 
  • Late gadolinium cardiovascular magnetic resonance in the assessment of myocardial viability. 
  • Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. 
  • Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents--comparison of Gd-EOB-DTPA and Gd-BOPTA. 
  • Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. 
  • Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? 
  • Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? 
  • Long-circulating liposomal contrast agents for magnetic resonance imaging. 
  • Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321. 
  • MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease. 
  • MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography? 
  • MRI of pulmonary embolism using Gd-DTPA-polyethylene glycol polymer enhanced 3D fast gradient echo technique in a canine model. 
  • MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study. 
  • Magnetic resonance imaging diagnosis of Takayasu arteritis. 
  • Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). 
  • Magnetic resonance imaging of a tissue/implanted device biointerface using in vivo microdialysis sampling. 
  • Magnetic resonance imaging of intramuscular myxoma with histological comparison and a review of the literature. 
  • Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome. 
  • Magnetic resonance imaging of the pancreas with gadolinium-DTPA. 
  • Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. 
  • Magnetic resonance microscopy of mouse embryos. 
  • Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed. 
  • Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. 
  • Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI. 
  • Meningioangiomatosis: CT and MR findings. 
  • Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study. 
  • Molecular imaging of cerebrovascular lesions. 
  • Morphologic phenotyping with MR microscopy: the visible mouse. 
  • Morphological studies of the murine heart based on probabilistic and statistical atlases. 
  • Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. 
  • Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. 
  • Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. 
  • Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. 
  • Nephrogenic systemic fibrosis: possible association with a predisposing infection. 
  • New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer? 
  • Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab. 
  • On fibrosis, prognosis, and the unique role of CMR: a paradigm shift from "bright is dead" to "bright is bad". 
  • Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. 
  • Paramagnetic polymerized liposomes as new recirculating MR contrast agents. 
  • Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. 
  • Perfusion MRI: the five most frequently asked technical questions. 
  • Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. 
  • Pitfalls in myocardial perfusion assessment with dynamic MR imaging after administration of a contrast material bolus in dogs. 
  • Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI. 
  • Presence of mechanical dyssynchrony in Duchenne muscular dystrophy. 
  • Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System. 
  • Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. 
  • Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. 
  • Pulmonary perfusion imaging in the rodent lung using dynamic contrast-enhanced MRI. 
  • Quantification of myocardial perfusion by MRI after coronary occlusion. 
  • Quantitative imaging of cartilage morphology at 3.0 Tesla in the presence of gadopentate dimeglumine (Gd-DTPA). 
  • Rapid three-dimensional MR imaging method for tracking a bolus of contrast agent through the brain. 
  • Redefinition of multiple sclerosis plaque size using diffusion tensor MRI. 
  • Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study. 
  • Renal excretion of gadolinium mimicking calculi on non-contrast CT. 
  • Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. 
  • Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. 
  • Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback? 
  • Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? 
  • Single breath-hold pulmonary magnetic resonance angiography. Optimization and comparison of three imaging strategies. 
  • Single-stage total endoscopic resection of a plexiform neurofibroma of the maxillary sinus in a child with type 1 neurofibromatosis. 
  • Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories. 
  • Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI. 
  • Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging. 
  • Successful therapy for trilateral retinoblastoma. 
  • Suspicious breast lesions detected at 3.0 T magnetic resonance imaging: clinical and histological outcomes. 
  • Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. 
  • The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations. 
  • The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. 
  • Three dimensional magnetic resonance microangiography of rat neurovasculature. 
  • [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. 
• 

  Keywords of People

  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Craciunescu, Oana, Professor of Radiation Oncology, Radiation Oncology
  • Johnson, G. Allan, Charles E. Putman University Distinguished Professor of Radiology, Biomedical Engineering
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology